Insulet Investors

The OmniPod Insulin Management System is a product developed, manufactured, and sold by Insulet Corporation.

Last Funding Type: Post-IPO Debt
Headquarters: Bedford, Massachusetts, United States
Total Funding: 129500000
Employee Number: 1001-5000
Funding Status: IPO
Industry: Biotechnology, Health Care, Medical Device
Estimated Revenue: $100M to $500M
Acquisitions Number: 1
Last Funding Date: 2009-03-16 00:00:00
Founded Date: 2000
Investors Number: 12